How are NRIX collar max profit and max loss calculated?

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NRIX collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 69.80%), the computed maximum profit is $109.00 per contract and the computed maximum loss is -$91.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a NRIX collar?

The breakeven for the NRIX collar priced on this page is roughly $26.91 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NRIX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 20.01%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current NRIX implied volatility affect this collar?

NRIX ATM IV is at 69.80% with IV rank near 5.58%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

NRIX Collar Strategy

NRIX (Nurix Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton’s tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.

NRIX (Nurix Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.76B, a beta of 1.79 versus the broader market, a 52-week range of 8.195-26.81, average daily share volume of 1.7M, a public-listing history dating back to 2020, approximately 317 full-time employees. These structural characteristics shape how NRIX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.79 indicates NRIX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a collar on NRIX?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

NRIX snapshot

As of August 14, 2026, spot at $27.06, ATM IV 69.80%, IV rank 5.58%, expected move 20.01%. The collar on NRIX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this collar structure on NRIX specifically: IV regime affects collar pricing on both sides; compressed NRIX IV at 69.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 20.01% (roughly $5.41 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NRIX expiries trade a higher absolute premium for lower per-day decay. Position sizing on NRIX should anchor to the underlying notional of $27.06 per share and to the trader's directional view on NRIX stock.

NRIX collar setup

The NRIX collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NRIX at $27.06 on that close, the first option leg uses a $28.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NRIX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NRIX shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$27.06	long
Sell 1	Call	$28.00	$2.50
Buy 1	Put	$26.00	$2.35

NRIX collar risk and reward

Net Premium / Debit: -$2,691.00
Max Profit (per contract): $109.00
Max Loss (per contract): -$91.00
Breakeven(s): $26.91
Risk / Reward Ratio: 1.198

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

NRIX collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on NRIX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$91.00
$5.99	-77.9%	-$91.00
$11.97	-55.8%	-$91.00
$17.96	-33.6%	-$91.00
$23.94	-11.5%	-$91.00
$29.92	+10.6%	+$109.00
$35.90	+32.7%	+$109.00
$41.88	+54.8%	+$109.00
$47.87	+76.9%	+$109.00
$53.85	+99.0%	+$109.00

When traders use collar on NRIX

Collars on NRIX hedge an existing long NRIX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

NRIX thesis for this collar

The market-implied 1-standard-deviation range for NRIX extends from approximately $21.65 on the downside to $32.47 on the upside. A NRIX collar hedges an existing long NRIX position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current NRIX IV rank near 5.58% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NRIX at 69.80%. As a Healthcare name, NRIX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NRIX-specific events.

NRIX collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NRIX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NRIX alongside the broader basket even when NRIX-specific fundamentals are unchanged. Always rebuild the position from current NRIX chain quotes before placing a trade.

Frequently asked questions

What is a collar on NRIX?: A collar on NRIX is the collar strategy applied to NRIX (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With NRIX stock at $27.06 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed NRIX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are NRIX collar max profit and max loss calculated?: Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NRIX collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 69.80%), the computed maximum profit is $109.00 per contract and the computed maximum loss is -$91.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a NRIX collar?: The breakeven for the NRIX collar priced on this page is roughly $26.91 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NRIX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 20.01%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on NRIX?: Collars on NRIX hedge an existing long NRIX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current NRIX implied volatility affect this collar?: NRIX ATM IV is at 69.80% with IV rank near 5.58%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.